• Sitemap
  • Contact us

pISSN 2384-2458 eISSN 2288-7261
Article View

Annual Report

J Lab Med Qual Assur 2016; 38(4): 169-193

Published online December 31, 2016

https://doi.org/10.15263/jlmqa.2016.38.4.169

Copyright © Korean Association of External Quality Assessment Service.

Annual Report on the External Quality Assessment Scheme for Clinical Microbiology in Korea (2015)

Jeonghyun Chang1, Mi-Na Kim1, Eui Chong Kim2, Jong Hee Shin3, Nam Yong Lee4, Sunjoo Kim5, Seok Hoon Jeong6, Jae- Seok Kim7, Chang Ki Kim8, Hye Gyung Bae9, Nam Surp Yoon1, Se Ik Joo2, Dong Joon Song4, Keonhan Kim6,Tae Jeon Jeong10, and Jin Heo11, as the Clinical Microbiology Subcommittee, Korean Association of External Quality Assessment Service

1Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine;
2Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul;
3Department of Laboratory Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju;
4Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul;
5Department of Laboratory Medicine, Kyungsang National University Hospital, Kyungsang National University School of Medicine, Jinju;
6Department of Laboratory Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine;
7Department of Laboratory Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul;
8Department of Laboratory Medicine, Korean Institute of Tuberculosis, Cheongju;
9Department of Laboratory Medicine, Greencross Reference Laboratory, Yongin;
10Department of Laboratory Medicine, Kosin University Gospel Hospital, Busan;
11Department of Laboratory Medicine, Korea University Ansan Hospital, Ansan, Korea

Correspondence to:Mi-Na Kim
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
Tel: +82-2-3010-4511 Fax: +82-2-478-0884 E-mail: mnkim@amc.seoul.kr

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Annual proficiency surveys were conducted in March, June, and September in 2015 by the Clinical Microbiology Subcommittee of the Korean Association of External Quality Assessment Service. The program covers the sections of bacteriology, advanced bacteriology and mycology, mycobacteriology, and parasitology. Each trial was composed of three sets of different combinations of five bacteria and yeasts. These sets were distributed among laboratories for Gram staining, culture, identification, and antimicrobial susceptibility tests. Five slides with fixed sputum smears were provided as part of each trial for acid-fast bacilli detection. The survey material distribution was section-based. Two survey materials were provided in each trial, while five specimens for mycobacterial culture and identification, five specimens for anti-tuberculosis susceptibility testing and two Mycobacterium tuberculosis strains for rapid detection of rifampin and isoniazid resistance were distributed in the March and June trials. Five virtual microscopy files for stool parasite examination were availed by registered participants in the June trial. Out of the 334 enrolled laboratories, 328 (98.2%), 328 (98.2%), and 329 (98.5%) submitted responses in trials I, II, and III, respectively. Identification of bacteria, namely, Escherichia coli , Klebsiella pneumoniae , Enterococcus faecalis , Pseudomonas aeruginosa , Streptococcus pneumoniae , and Vibrio fluvialis by more than 95% of participants was acceptable. Surveillance cultures for vancomycin-resistant enterococci and carbapenem-resistant Enterobacteriaceae were determined accurately by 75.8%−85.3% and 93.1% of the respondents, respectively. Species-level identification of Candida krusei , Candida lusitanae , and Candida guilliermondii was still low at 79.8%, 55.7%, and 42.7%, respectively. Disk diffusion method revealed an unacceptably high false-positive rate of resistance to glycopeptides in E. faecalis and to trimethoprim-sulfamethoxazole in S . pneumoniae . Advanced bacteriology trials revealed unsatisfactory results for species-level identification of moulds. Mycobacterial culture, identification and susceptibility testing, and molecular detection of rifampin and isoniazid resistance were performed exceedingly well by participants. Hymenolepsis diminuta could not be identified by participants, with a correct answer rate of only 46.5% and ‘no parasite seen’ answer rate of only 31.8% for negative specimens. Species-level identification of Candida and moulds was challenging for clinical microbiology laboratories. Disk diffusion method was found to be problematic in testing the susceptibility of microorganisms to glycopeptides and trimethoprim-sulfamethoxazole. Improvement is required in result interpretation of negative specimens in parasitology.

Keywords: Quality control, Parasitology, Bacteriology, Microbiology, Mycobacterium, Antimicrobial susceptibility

References

  1. Jones RN, Glick T, Sader HS, Flamm RK, Ross JE, Rhomberg PR, et al. Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011. Diagn Microbiol Infect Dis 2013;75:357-60.
    Pubmed CrossRef
  2. Snell JJ, Brown DF, Perry SF, George R. Antimicrobial susceptibility testing of enterococci: results of a survey conducted by the United Kingdom National External Quality Assessment Scheme for Microbiology. J Antimicrob Chemother 1993;32:401-11.
    Pubmed CrossRef
  3. Chaitram JM, Jevitt LA, Lary S, Tenover FC; WHO Antimicrobial Resistancce Group. The World Health Organization's External Quality Assurance System Proficiency Testing Program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS methods. J Clin Microbiol 2003;41:2372-7.
    KoreaMed CrossRef
  4. EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_4.0.pdf (Accessed January 1, 2014).
  5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 24th informational supplement, M100-S24. Wayne (PA):Clinical and Laboratory Standards Institute, 2014.
  6. Spellerberg B, Brandt C. Special phenotypic methods for detecting antibacterial resistance. In: Swenson JM, Patel JB, Jorgensen JH, editors. Manual of clinical microbiology. 10th ed. Washington (DC): ASM Press, 2011;1168.
  7. Ko YJ, Kim MN, Kim EC, Shin JH, Lee NY, Kim S, et al. Annual report on external quality assessment scheme in clinical microbiology in Korea (2013). J Lab Med Qual Assur 2014;36:122-39.
    CrossRef
  8. Espinel-Ingroff A, Pfaller MA, Bustamante B, Canton E, Fothergill A, Fuller J, et al. Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother 2014;58:2006-12.
    Pubmed KoreaMed CrossRef
  9. Castanheira M, Woosley LN, Diekema DJ, Jones RN, Pfaller MA. Candida guilliermondii and other species of candida misidentified as Candida famata: assessment by vitek 2, DNA sequencing analysis, and matrixassisted laser desorption ionization-time of flight mass spectrometry in two global antifungal surveillance programs. J Clin Microbiol 2013;51:117-24.
    Pubmed KoreaMed CrossRef
  10. Jeong HS, Bae IK, Shin JH, Jung HJ, Kim SH, Lee JY, et al. Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae. Korean J Lab Med 2011;31:257-64.
    Pubmed KoreaMed CrossRef
  11. Kim MH, Lee HJ, Park KS, Suh JT. Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea. Yonsei Med J 2010;51:76874.
  12. Ko YJ, Kim MN, Kim EC, Shin JH, Lee NY, Kim S, et al. Annual report on external quality assessment scheme for clinical microbiology in Korea (2014). J Lab Med Qual Assur 2015;37:153-78.
    CrossRef
  13. Sader HS, Fritsche TR, Jones RN. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents. J Clin Microbiol 2006;44:1101-4.
    Pubmed KoreaMed CrossRef
  14. Chun S, Huh HJ, Lee NY. Species-specific difference in antimicrobial susceptibility among viridans group streptococci. Ann Lab Med 2015;35:205-11.
    Pubmed KoreaMed CrossRef

Share this article on :

Stats or metrics